Cytovation raises USD20 million in Series A round led by Sandwater and Canica
Cytovation AS, a clinical stage immune-oncology company has closed its Series A financing round, raising a total of NOK180 million (USD20 million). The Series A round was led by Sandwater, a Norwegian venture capital firm that invests in groundbreaking companies across a range of industries including life sciences, and Canica,
